<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Yale J Biol Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Yale J Biol Med</journal-id>
      <journal-id journal-id-type="pmc">yjbm</journal-id>
      <journal-id journal-id-type="publisher-id">YJBM</journal-id>
      <journal-title-group>
        <journal-title>The Yale Journal of Biology and Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0044-0086</issn>
      <issn pub-type="epub">1551-4056</issn>
      <publisher>
        <publisher-name>YJBM</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25506288</article-id>
      <article-id pub-id-type="pmc">4257040</article-id>
      <article-id pub-id-type="publisher-id">yjbm874563</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Heart Block and Acute Kidney Injury Due to Hyperparathyroidism-Induced Hypercalcemic Crisis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Brown</surname>
            <given-names>Taylor C.</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="A1">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Healy</surname>
            <given-names>James M.</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="A1">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McDonald</surname>
            <given-names>Mary J.</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="A2">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hansson</surname>
            <given-names>Joni H.</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="A3">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Quinn</surname>
            <given-names>Courtney E.</given-names>
          </name>
          <degrees>MD, MS</degrees>
          <xref ref-type="aff" rid="A1">a</xref>
          <xref ref-type="corresp" rid="COR1">*</xref>
        </contrib>
        <aff id="A1"><label>a</label>Department of Surgery, Section of Endocrine Surgery, Yale School of Medicine, New Haven, Connecticut</aff>
        <aff id="A2"><label>b</label>Department of Pathology, Yale School of Medicine, New Haven, Connecticut</aff>
        <aff id="A3"><label>c</label>Department of Internal Medicine, Section of Nephrology, Yale School of Medicine, New Haven, Connecticut</aff>
      </contrib-group>
      <author-notes>
        <corresp id="COR1"><label>*</label>To whom all correspondence should be addressed: Courtney E. Quinn, MD, MS, Assistant Professor of Surgery, Department of Surgery, Section of Endocrine Surgery, Yale School of Medicine, 330 Cedar St., FMB 130, Box 208062, New Haven, CT 06520; Tele: 203-737-2036; Fax: 203-785-2498; Email: <email>courtney.quinn@yale.edu</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>12</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2014</year>
      </pub-date>
      <volume>87</volume>
      <issue>4</issue>
      <fpage>563</fpage>
      <lpage>567</lpage>
      <permissions>
        <copyright-statement>Copyright &#xA9;2014, Yale Journal of Biology and
Medicine</copyright-statement>
        <copyright-year>2014</copyright-year>
        <copyright-holder>Yale Journal of Biology and Medicine</copyright-holder>
        <license license-type="open access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We describe a patient who presented with multi-system organ failure due to extreme hypercalcemia (serum calcium 19.8 mg/dL), resulting from primary hyperparathyroidism. He was found to have a 4.8 cm solitary atypical parathyroid adenoma. His course was complicated by complete heart block, acute kidney injury, and significant neurocognitive disturbances. Relevant literature was reviewed and discussed. Hyperparathyroidism-induced hypercalcemic crisis (HIHC) is a rare presentation of primary hyperparathyroidism and only a small minority of these patients develop significant cardiac and renal complications. In cases of HIHC, a multidisciplinary effort can facilitate rapid treatment of life-threatening hypercalcemia and definitive treatment by surgical resection. As such, temporary transvenous cardiac pacing and renal replacement therapy can provide a life-saving bridge to definitive parathyroidectomy in cases of HIHC.</p>
      </abstract>
      <kwd-group>
        <kwd>hyperparathyroidism</kwd>
        <kwd>hypercalcemic crisis</kwd>
        <kwd>heart block</kwd>
        <kwd>acute kidney injury</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p>Primary hyperparathyroidism (PHPT) is a common endocrine disorder, affecting approximately 0.1 percent to 0.3 percent of the population [<xref rid="R1" ref-type="bibr">1</xref>]. PHPT is most commonly caused by a single parathyroid adenoma (85 percent), followed by multiple adenomas or four gland hyperplasia (15 percent), and rarely parathyroid carcinoma (&lt;1 percent) [<xref rid="R1" ref-type="bibr">1</xref>]. Hyperparathyroidism-induced hypercalcemic crisis (HIHC) is a rare but life-threatening presentation of PHPT. The patient&#x2019;s course can be complicated by multiple concurrent co-morbidities, including cardiac arrhythmias, acute kidney injury, severe hypovolemia, obtundation, and various gastrointestinal disturbances [<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref>]. In addition, these patients are more likely to have larger, atypical glands present in ectopic locations, as well as a higher incidence of parathyroid carcinoma [<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref>]. Despite these challenges, patients presenting with HIHC can be successfully treated with intensive medical support and emergent parathyroidectomy, producing long-term, durable results [<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref>].</p>
    </sec>
    <sec id="s2">
      <title>Case Presentation</title>
      <p>A 70-year-old gentleman from Ecuador presented to Yale-New Haven Hospital following several days of worsening weakness, fatigue, anorexia, and constipation. He also noted 15 pounds of unintentional weight loss over the past 6 months. His initial laboratory evaluation was remarkable for a significantly elevated serum calcium level of 19.8 mg/dL (8.4 &#x2013; 10.2 mg/dL), a parathyroid hormone (PTH) level of 1,650 pg/mL (10.0 &#x2013; 65.0 pg/dL), and a serum creatinine level of 3.0 mg/dL (0.6 &#x2013; 1.2 mg dL). His medical history included hypertension, hyperlipidemia, and gastroesophageal reflux disorder, all well controlled medically. He denied a prior history of hypercalcemia or related symptoms. Of note, despite complaints of weakness and fatigue, he completed a hike to the summit of a local mountain in Connecticut several days prior to admission.</p>
      <p>The patient was admitted to the medical intensive care unit in hypercalcemic crisis, accompanied by acute kidney injury. His hypercalcemia was emergently treated with aggressive intravenous fluid resuscitation, calcitonin, bisphosphonates, and renal replacement therapy via a temporary venous catheter. On surgical evaluation, the patient was also noted to be lethargic with some mental slowing. His course was then complicated by symptomatic paroxysmal atrioventricular (AV) block that required the placement of a temporary transvenous pacemaker (<xref ref-type="fig" rid="F1">Figure 1</xref>). An ultrasound of the neck demonstrated a 4.8 x 4.0 x 2.9 cm mass in the right neck, consistent with an enlarged right parathyroid gland (<xref ref-type="fig" rid="F2">Figure 2a</xref>). A sestamibi scan demonstrated focal radiotracer uptake, corresponding to the region of the enlarged parathyroid gland.</p>
      <p>With a working diagnosis of PHPT due to a parathyroid adenoma and concern for potential parathyroid carcinoma, he underwent a focused parathyroidectomy after his arrhythmia was stabilized. An enlarged parathyroid gland, spanning the entire length of the right thyroid lobe, was readily identified (<xref ref-type="fig" rid="F2">Figure 2b</xref>). The gland was soft and contained a large inferior cystic component. The tumor easily dissected free from surrounding tissues, and there was no gross evidence of malignant invasion (<xref ref-type="fig" rid="F2">Figure 2b</xref> and <xref ref-type="fig" rid="F2">2c</xref>). Intra-operative intact PTH levels were measured, and a baseline level of 5,200 pg/ml decreased to a nadir of 507 pg/ml 40 minutes following resection of the parathyroid adenoma. Pathological examination of the gland did not identify any features of malignancy, including capsular invasion, prominent nucleoli, thick fibrous bands, or vascular invasion, and the tumor was classified as an atypical parathyroid adenoma (<xref ref-type="fig" rid="F2">Figure 2d</xref>).</p>
      <p>After successful parathyroidectomy, the arrhythmia and renal dysfunction abated, and his pacemaker and dialysis catheters were removed on post-operative day 4 and 5, respectively. He was discharged to his home. Two months after surgery, the patient&#x2019;s calcium and PTH level were 9.6 mg/dL and 32 pg/mL, respectively, consistent with resolution of PHPT. At that time, the patient&#x2019;s symptoms had resolved, and he was feeling well.</p>
    </sec>
    <sec sec-type="discussion" id="s3">
      <title>Discussion</title>
      <p>One notable aspect of the patient&#x2019;s course was the development of heart block, requiring temporary transvenous pacemaker placement. Most cases of PHPT present with mild-to-moderate hypercalcemia with limited effect on cardiac function. In one study that assessed electrocardiogram (ECG) changes in patients with PHPT and modest hypercalcemia, patients demonstrated QT and QTc interval shortening that resolved after parathyroidectomy. These patients never developed significant cardiac dysfunction or arrhythmias, such as supraventricular or ventricular arrhythmias, or high-grade AV-block. The authors concluded that moderate hypercalcemia had no immediate, clinically significant effects on cardiac conduction [<xref rid="R4" ref-type="bibr">4</xref>]. Patients with chronic, mild-to-moderate hypercalcemia due to PHPT, however, have been shown to demonstrate subtle changes in cardiac structure and physiology, including left ventricular hypertrophy, cardiac and vascular calcifications, and diastolic dysfunction [<xref rid="R5" ref-type="bibr">5</xref>]. Furthermore, patients with symptomatic PHPT have been shown to be at higher risk of cardiac death before and after parathyroidectomy [<xref rid="R5" ref-type="bibr">5</xref>].</p>
      <p>Significant cardiac arrhythmias, including heart block and ventricular arrhythmias, although rare, are known complications of hypercalcemic crisis. In one retrospective study of 67 patients presenting with HIHC, only two patients (3 percent) suffered from cardiac arrhythmias [<xref rid="R2" ref-type="bibr">2</xref>]. In a similar study of 34 patients presenting with HIHC, no patients demonstrated evidence of cardiac arrhythmia [<xref rid="R3" ref-type="bibr">3</xref>]. Most other reports of HIHC-induced cardiac arrhythmia are annotated in case reports. A review of these demonstrates that the presentation of significant cardiac arrhythmia associated with HIHC can be highly variable, including tachy-brady syndrome, ventricular tachycardia, ventricular fibrillation, and paroxysmal atrioventricular block [<xref rid="R6" ref-type="bibr">6</xref>-<xref rid="R9" ref-type="bibr">9</xref>]. While life-threatening cardiac arrhythmias are rare during HIHC, ECG changes, including QT interval shortening, are frequent [<xref rid="R4" ref-type="bibr">4</xref>].</p>
      <p>Our patient required the placement of a temporary transvenous pacemaker to treat complete heart block secondary to hypercalcemia. This intervention stabilized the patient&#x2019;s cardiac arrhythmia and allowed for emergent parathyroidectomy. Increasingly, temporizing pacemaker placement is being used in critically ill patients as a bridge to definitive therapy or recovery of non-compromising heart rhythm [<xref rid="R10" ref-type="bibr">10</xref>]. Life-threatening cardiac arrhythmias are rare complications of HIHC, and our experience demonstrates that placement of a temporary pacemaker can serve as a critical adjunct to treatment.</p>
      <p>The patient&#x2019;s course was also notable for non-oliguric acute kidney injury, requiring emergent hemodialysis due to refractory hypercalcemia. In chronic PHPT, renal dysfunction is reported to have a prevalence of approximately 16 to 17 percent [<xref rid="R11" ref-type="bibr">11</xref>]. In mild, asymptomatic cases of PHPT, significant renal impairment is infrequently noted, and renal function usually does not deteriorate over time. In contrast, moderate to severe symptomatic PHPT is frequently associated with renal impairment, and renal function usually deteriorates over time if left untreated [<xref rid="R12" ref-type="bibr">12</xref>]. Indeed, higher levels of PTH are associated with an increased risk of developing end-stage renal disease due to PHPT [<xref rid="R13" ref-type="bibr">13</xref>].</p>
      <p>The acute effects of HIHC upon renal function are less understood. In one case series of 67 patients with HIHC, 20.8 percent were noted to be suffering from nephrolithiasis, but serum creatinine levels were not noted [<xref rid="R2" ref-type="bibr">2</xref>]. In a similar case series of 34 patients presenting with HIHC, the mean pre-operative creatinine level was significantly higher than observed in non-crisis patients with PHPT. However, after parathyroidectomy, both groups&#x2019; creatinine levels returned to normal, indicating that the more severe renal impairment observed in HIHC is reversible [<xref rid="R3" ref-type="bibr">3</xref>]. In neither case series was use of renal replacement therapy noted.</p>
      <p>The patient&#x2019;s presentation was also notable for neurocognitive disturbances that included anorexia, fatigue, and lethargy. Neurocognitive disturbance occur frequently in PHPT but have been shown to occur at a higher rate and of a greater severity in the setting of HIHC [<xref rid="R3" ref-type="bibr">3</xref>]. Though the exact mechanism remains incompletely understood, these changes have been attributed to hypercalcemia altering neurotransmitter function [<xref rid="R14" ref-type="bibr">14</xref>]. It has been shown that parathyroidectomy reduces mood and anxiety symptoms in PHPT patients [<xref rid="R15" ref-type="bibr">15</xref>]. Due to the patient&#x2019;s acute kidney injury, he also suffered from additional metabolic derangements that could have also contributed to his neurocognitive changes.</p>
    </sec>
    <sec sec-type="conclusions" id="s4">
      <title>Conclusions</title>
      <p>In summary, we present a unique case of hypercalcemic crisis caused by PHPT. The patient&#x2019;s presenting hypercalcemia of 19.8 mg/dL was significantly higher than noted in previous case series of HIHC, which had reported values of 13.95 &#xB1; 0.19 md/dL and 15.8 &#xB1; 2.1 md/dL [<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref>]. As a result, the patient suffered multi-system organ failure, including life-threatening heart block and acute kidney injury. As such, the patient&#x2019;s care required a multi-disciplinary effort that included endocrine surgery, endocrinology, nephrology, interventional cardiology, internal medicine, and critical care specialists.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>HIHC</term>
          <def>
            <p>hyperparathyroidism-induced hypercalcemic crisis</p>
          </def>
        </def-item>
        <def-item>
          <term>PHPT</term>
          <def>
            <p>primary hyperparathyroidism</p>
          </def>
        </def-item>
        <def-item>
          <term>PTH</term>
          <def>
            <p>parathyroid hormone</p>
          </def>
        </def-item>
        <def-item>
          <term>ECG</term>
          <def>
            <p>electrocardiogram</p>
          </def>
        </def-item>
        <def-item>
          <term>AV</term>
          <def>
            <p>atrioventricular</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <notes>
      <sec>
        <title>Author contributions</title>
        <p>TCB, JMH, and CEQ drafted the manuscript and created its corresponding figures. MJM provided a pathological review and a histological photo of the parathyroid adenoma. JHH provided expert opinion concerning the patient&#x2019;s acute kidney injury.</p>
      </sec>
    </notes>
    <ref-list>
      <ref id="R1">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Fernandez-Ranvier</surname>
            <given-names>GG</given-names>
          </name>
          <name>
            <surname>Khanafshar</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zarnegar</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kebebew</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
          <article-title>Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis?</article-title>
          <source>Cancer</source>
          <year>2007</year>
          <volume>110</volume>
          <issue>2</issue>
          <fpage>255</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="pmid">17559137</pub-id>
        </element-citation>
      </ref>
      <ref id="R2">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Starker</surname>
            <given-names>LF</given-names>
          </name>
          <name>
            <surname>Bjorklund</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Theoharis</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Long</surname>
            <given-names>WD</given-names>
            <suffix>3rd</suffix>
          </name>
          <name>
            <surname>Carling</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Udelsman</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Clinical and histopathological characteristics of hyperparathyroidism-induced hypercalcemic crisis</article-title>
          <source>World J Surg</source>
          <year>2011</year>
          <volume>35</volume>
          <issue>2</issue>
          <fpage>331</fpage>
          <lpage>335</lpage>
          <pub-id pub-id-type="pmid">21042912</pub-id>
        </element-citation>
      </ref>
      <ref id="R3">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Beck</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Lew</surname>
            <given-names>JI</given-names>
          </name>
          <name>
            <surname>Solorzano</surname>
            <given-names>CC</given-names>
          </name>
          <article-title>Hypercalcemic crisis in the era of targeted parathyroidectomy</article-title>
          <source>J Surg Res</source>
          <year>2011</year>
          <volume>171</volume>
          <issue>2</issue>
          <fpage>404</fpage>
          <lpage>408</lpage>
          <pub-id pub-id-type="pmid">21658721</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Rosenqvist</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nordenstrom</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Andersson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Edhag</surname>
            <given-names>OK</given-names>
          </name>
          <article-title>Cardiac conduction in patients with hypercalcaemia due to primary hyperparathyroidism</article-title>
          <source>Clin Endocrinol (Oxf)</source>
          <year>1992</year>
          <volume>37</volume>
          <issue>1</issue>
          <fpage>29</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="pmid">1424189</pub-id>
        </element-citation>
      </ref>
      <ref id="R5">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Andersson</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rydberg</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Willenheimer</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Primary hyperparathyroidism and heart disease--a review</article-title>
          <source>Eur Heart J</source>
          <year>2004</year>
          <volume>25</volume>
          <issue>20</issue>
          <fpage>1776</fpage>
          <lpage>1787</lpage>
          <pub-id pub-id-type="pmid">15474692</pub-id>
        </element-citation>
      </ref>
      <ref id="R6">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Carpenter</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>May</surname>
            <given-names>ME</given-names>
          </name>
          <article-title>Case report: cardiotoxic calcemia</article-title>
          <source>Am J Med Sci</source>
          <year>1994</year>
          <volume>307</volume>
          <issue>1</issue>
          <fpage>43</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">8291506</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Kiewiet</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Ponssen</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Janssens</surname>
            <given-names>EN</given-names>
          </name>
          <name>
            <surname>Fels</surname>
            <given-names>PW</given-names>
          </name>
          <article-title>Ventricular fibrillation in hypercalcaemic crisis due to primary hyperparathyroidism</article-title>
          <source>Neth J Med</source>
          <year>2004</year>
          <volume>62</volume>
          <issue>3</issue>
          <fpage>94</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="pmid">15209475</pub-id>
        </element-citation>
      </ref>
      <ref id="R8">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Occhetta</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Bortnik</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Magnani</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Francalacci</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Vassanelli</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Primary hyperparathyroidism and arrhythmic storm in a patient with an implantable cardioverter defibrillator for primary prevention of sudden death</article-title>
          <source>Europace</source>
          <year>2004</year>
          <volume>6</volume>
          <issue>3</issue>
          <fpage>184</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">15121067</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Vosnakidis</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Polymeropoulos</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zarogoulidis</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Zarifis</surname>
            <given-names>I</given-names>
          </name>
          <article-title>Atrioventricular nodal dysfunction secondary to hyperparathyroidism</article-title>
          <source>J Thorac Dis</source>
          <year>2013</year>
          <volume>5</volume>
          <issue>3</issue>
          <fpage>E90</fpage>
          <lpage>E92</lpage>
          <pub-id pub-id-type="pmid">23825791</pub-id>
        </element-citation>
      </ref>
      <ref id="R10">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Kornberger</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schmid</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kalender</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Stock</surname>
            <given-names>UA</given-names>
          </name>
          <name>
            <surname>Doernberger</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Khalil</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
          <article-title>Bridge to recovery or permanent system implantation: an eight-year single-center experience in transvenous semipermanent pacing</article-title>
          <source>Pacing Clin Electrophysiol</source>
          <year>2013</year>
          <volume>36</volume>
          <issue>9</issue>
          <fpage>1096</fpage>
          <lpage>1103</lpage>
          <pub-id pub-id-type="pmid">23718817</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Walker</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Nickolas</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kepley</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>McMahon</surname>
            <given-names>DJ</given-names>
          </name>
          <etal/>
          <article-title>Predictors of Renal Function in Primary Hyperparathyroidism</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2014</year>
          <volume>99</volume>
          <issue>5</issue>
          <fpage>1885</fpage>
          <lpage>1892</lpage>
          <pub-id pub-id-type="pmid">24527717</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Marcocci</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cetani</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Clinical practice. Primary hyperparathyroidism</article-title>
          <source>N Engl J Med</source>
          <year>2011</year>
          <volume>365</volume>
          <issue>25</issue>
          <fpage>2389</fpage>
          <lpage>2397</lpage>
          <pub-id pub-id-type="pmid">22187986</pub-id>
        </element-citation>
      </ref>
      <ref id="R13">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Tassone</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Gianotti</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Emmolo</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Ghio</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Borretta</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2009</year>
          <volume>94</volume>
          <issue>11</issue>
          <fpage>4458</fpage>
          <lpage>4461</lpage>
          <pub-id pub-id-type="pmid">19808852</pub-id>
        </element-citation>
      </ref>
      <ref id="R14">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Grant</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Velusamy</surname>
            <given-names>A</given-names>
          </name>
          <article-title>What is the best way of assessing neurocognitive dysfunction in patients with primary hyperparathyroidism?</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2014</year>
          <volume>99</volume>
          <issue>1</issue>
          <fpage>49</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="pmid">24203059</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Roman</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Sosa</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Pietrzak</surname>
            <given-names>RH</given-names>
          </name>
          <name>
            <surname>Snyder</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Udelsman</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
          <article-title>The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism</article-title>
          <source>Ann Surg</source>
          <year>2011</year>
          <volume>253</volume>
          <issue>1</issue>
          <fpage>131</fpage>
          <lpage>137</lpage>
          <pub-id pub-id-type="pmid">21233611</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p><bold>Electrocardiogram (ECG) of patient.</bold> The ECG demonstrates a symptomatic episode of complete heart block prior to pacemaker placement and parathyroidectomy.</p>
      </caption>
      <graphic xlink:href="yjbm_87_4_563_g01"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p><bold>Ultrasound (US), intra-operative, and histological images of parathyroid adenoma.</bold> Arrows denote tumor boundaries. <bold>a)</bold> A pre-operative US demonstrates an enlarged right parathyroid gland containing a cystic component and abutting the carotid artery (CA). <bold>b)</bold> The intra-operative photograph is of the enlarged parathyroid gland with its major vascular pedicle isolated prior to ligation. <bold>c)</bold> The intra-operative photograph is of the excised parathyroid adenoma. <bold>d)</bold> The microphotograph at 10X magnification is of a H&amp;E stain of the tumor demonstrating a cellular parathyroid gland, composed of a uniform population of oncocytic cells in a solid, nested, and trabecular growth pattern.</p>
      </caption>
      <graphic xlink:href="yjbm_87_4_563_g02"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
